Pharmaceutical Technology

MAY 23, 2023

The global pharmaceutical industry experienced a 23% decline in the number of environmental sustainability-related patent applications in Q1 2023 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 24% in Q1 2023, according to GlobalData’s Patent Analytics. in Q1 2023.

Pharmaceutical 52

Pharmaceutical Government Pharmaceutical manufacturing Manufacturing 52

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Government 40

Government Pharmaceutical Pharmaceutical manufacturing Manufacturing 40

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical 40

Pharmaceutical Pharmaceutical manufacturing Government Manufacturing 40

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Healthcare 52

European Pharmaceutical Review

JUNE 3, 2024

Innovations in the process spectroscopy market molecular spectroscopy accounted for the greatest share of the process spectroscopy market between 2023 to 2033″ The analysis found that molecular spectroscopy accounted for the greatest share of the process spectroscopy market between the 2023 to 2033 forecast period.

Marketing 97

Marketing Manufacturing Pharmaceutical manufacturing Pharmaceutical 97

European Pharmaceutical Review

MAY 31, 2023

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. It investigated how excessive inventories are affecting the industry and what factors could influence inventory growth in 2023. This makes it difficult to respond swiftly to changes in demand, the report found.

Management 111

Management Pharma Pharmaceutical manufacturing Medicine 111

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Marketing 69

Marketing Pharmaceutical Leads Manufacturing 69

European Pharmaceutical Review

NOVEMBER 14, 2023

The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. Article: Are we globally prepared for the next pandemic?

Manufacturing 110

Manufacturing Pharmaceutical manufacturing Pharmaceutical Competition 110

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 26, 2022

The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025. Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. Reducing the facilities carbon impact will also be supported by the expansion. AbbVie announces Michael Severino, M.D.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

JUNE 6, 2023

Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Pharma 98

European Pharmaceutical Review

SEPTEMBER 28, 2023

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.

Manufacturing 98

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 98

Impetus Digital

AUGUST 2, 2024

Looking back at 2023 , AI for drug discovery saw both wins and losses. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

OCTOBER 25, 2023

Combination Therapy in Oncology Combination therapies comprising two or more therapeutic agents have become a cornerstone of oncology management and are increasingly a development focus for the pharmaceutical industry. When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Marketing Pharmaceutical manufacturing 105

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] The food sector has already initiated the publication of preliminary regulations aimed at restricting PFAS in packaging. [3].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

JULY 21, 2023

Europe, too, has faced similar issues with its pharmaceutical supply chain, including critical shortages of antibiotics such as amoxicillin. Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

PM360

SEPTEMBER 30, 2024

In late 2023, Deloitte found that over half of 105 surveyed global biopharma leaders were committed to reducing environmental impact and advancing sustainability by minimizing water use, sourcing sustainable materials, and overhauling supply chains.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Clarify Health

OCTOBER 26, 2021

The American Medical Association’s 2021-2023 Organizational Strategic Plan to Embed Racial Justice and Advance Health Equity In February 2021, the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research issued new recommendations in five specific areas to broaden oncology trial eligibility criteria to include minorities.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52